by Sam Eskandari | May 31, 2018 | News
VANCOUVER, British Columbia, May 31, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide a corporate update on its achievements, related scientific activities and growth strategies for the second...
by Sam Eskandari | May 15, 2018 | News
VANCOUVER, British Columbia, May 15, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce with the dealer licence being granted which was previously announced on December 28, 2017, the Company has...
by Sam Eskandari | May 10, 2018 | News
VANCOUVER, British Columbia, May 10, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the recommendation issued by Members of the Standing Senate Committee on Aboriginal Peoples...
by Sam Eskandari | May 7, 2018 | News
May 4, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) is pleased to announce the establishment of new subsidiary Veritas Pharma Puerto Rico LLC (“Veritas PR”) in the US territory. With the...
by Sam Eskandari | Apr 19, 2018 | News
VANCOUVER, British Columbia, April 18, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, DSP, a consultant in safety pharmacology, has joined its advisory...
